Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Placebo-Controlled, Double-blind, Fixed-Dose, Multiple Cohort, Multiple Crossover, Dose-Finding Study of Oral BTD-001 in Adults With Idiopathic Hypersomnia (IH) or Narcolepsy Type 2

NCT02512588 is registered in ClinicalTrials.gov with Balance Therapeutics as lead sponsor.

NCT NCT02512588
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02512588 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Placebo-Controlled, Double-blind, Fixed-Dose, Multiple Cohort, Multiple Crossover, Dose-Finding Study of Oral BTD-001 in Adults With Idiopathic Hypersomnia (IH) or Narcolepsy Type 2
Lead sponsor
Balance Therapeutics
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2015
Completion date
February 28, 2018
Enrollment
120 (estimated)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

idiopathic hypersomnia, narcolepsy without cataplexy